MEDPASYL
Board
2 directors, last change in 2023Director (not named in the articles)
in office according to the deed of 26-09-2023
earlier manager, until 26-09-2023
Director (not named in the articles)
in office according to the deed of 26-09-2023
earlier manager, until 26-09-2023
also on the board of 1 other company
Mandates through the years
4 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
Gérants non statutaires
Gérants non statutaires
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director (not named in the articles), since before 26-09-2023
- Manager, until 26-09-2023
-
- Director (not named in the articles), since before 26-09-2023
- Manager, until 26-09-2023
-
- Gérants non statutaires, from before 24-03-2017, last mentioned in 2017
-
- Gérants non statutaires, from before 24-03-2017, last mentioned in 2017
Control
Shareholder
93 voting rights
share not stated
This company
MEDPASYL
Equity €346,190
Profit €58,397 in 2025
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
Source: shareholder structure in its own accounts
Articles of association
deed of 26-09-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Respecter et faire respecter dispositions légales Art de Guérir et déontologie médicale, avec ou sans limitation de durée”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Article 8, admission nécessite accord unanime des autres actionnaires”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 18:00
Shareholders
2 ownersOwners 2
- natural personSourceown accounts 2017share not stated
- natural personSourceown accounts 2017share not stated
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 26-09-2023 ↗
- 93 shares
- 93 shares
Capital over time
- 26-09-2023 Converted to unavailable equity · €12,400